borderline significantP = .051
Fluorescein staining score (FSS) Analysis of studies measuring ocular FSS at 4 weeks ( k = 6) showed a borderline significant improvement (SMD = −0.68, 95% CI = [−1.36, 0.00], P = .051; I 2 = 79.2%; Figure 3 (B).
Fluorescein staining score (FSS) Analysis of studies measuring ocular FSS at 4 weeks ( k = 6) showed a borderline significant improvement (SMD = −0.68, 95% CI = [−1.36, 0.00], P = .051; I 2 = 79.2%; Figure 3 (B).
Fluorescein staining scores showed a reduction approaching statistical significance (SMD = −0.68; P = .051), while symptom scores measured by ocular surface disease index trended toward improvement, also approaching significance (SMD = −1.17; P = .055).
Fluorescein ocular surface staining scores (SMD = −0.68; P = .051) and patient-reported outcomes (SMD = −1.17; P = .055) showed trends toward improvement, though these results did not reach statistical significance and should be interpreted cautiously.
While several studies employed validated grading systems such as the NEI or van Bijsterveld scales, inconsistent use and reporting limited comparability and may have contributed to the borderline significance observed in staining outcomes.